Skip to main navigation Skip to search Skip to main content

A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis

  • SR Muthuramalingam
  • , JP Braybrooke
  • , Andrew Blann
  • , S Madhusudan
  • , S Wilner
  • , A Jenkins
  • , C Han
  • , K Kaur
  • , T Perren
  • , TS Ganesan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science